Immune checkpoint inhibitor-related pneumonitis and COVID-19: a case-matched comparison of CT findings
Author:
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11547-023-01598-6.pdf
Reference26 articles.
1. Hodi FS, O’Day SJ, McDermott DF et al (2010) Improved survival with Ipilimumab in patients with metastatic melanoma. N Engl J Med 363:711–723. https://doi.org/10.1056/NEJMoa1003466
2. Wilky BA (2019) Immune checkpoint inhibitors: the linchpins of modern immunotherapy. Immunol Rev 290:6–23. https://doi.org/10.1111/imr.12766
3. Nishino M, Sholl LM, Hatabu H, Ramaiya NH, Hodi FS (2015) Anti-PD-1–relatedpneumonitis during cancer immunotherapy. N Engl J Med 373:288–290. https://doi.org/10.1056/NEJMc1505197
4. Thompson JA, Schneider BJ, Brahmer J et al (2019) Management of immunotherapy related toxicities, Version 1.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 17:255–289. https://doi.org/10.6004/jnccn.2019.0013
5. Schneider BJ, Naidoo J, Santomasso BD et al (2021) Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update. J Clin Oncol 39:4073–4126. https://doi.org/10.1200/JCO.21.01440
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fundamental misunderstandings and methodological flaws in "exploring kappa statistics considerations between two raters" by Yu et al;La radiologia medica;2024-08-20
2. Immune checkpoint inhibitors and SARS-CoV2 infection;International Immunopharmacology;2024-08
3. Exploring kappa statistics considerations between two raters;La radiologia medica;2024-06-25
4. The Clinical Analysis of Checkpoint Inhibitor Pneumonitis with Different Severities in Lung Cancer Patients: A Retrospective Study;Journal of Clinical Medicine;2024-01-01
5. Checkpoint Inhibitor-Induced Pneumonitis: Incidence and Management;Current Pulmonology Reports;2023-07-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3